D-Wave Quantum (QBTS) announced that it has been named a Leader in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment, becoming one of only two companies placed in the Leaders ...

D-Wave's commercial traction and recent acquisition clash with Rigetti's government ties and in-house chip design, but both ...

D-Wave Quantum Inc. (NYSE: QBTS), ("D-Wave" or the "Company"), the only dual-platform quantum computing company providing both annealing and gate-model systems, software, and serv ...

D-Wave is selected to receive $1.6 million from the National Science Foundation. It’s the company’s latest federal funding ...

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company ...

In June 2026, President Trump signed executive orders and committed multi-billion-dollar federal funding to accelerate U.S. quantum computing development and adoption of quantum-resistant encryption, ...

D-Wave has transitioned from proof-of-concept to large-scale commercial quantum deals, securing major contracts and accelerating revenue growth. QBTS's acquisition of Quantum Circuits, Inc. positions ...

With market capitalization of $9.15 billion, D-Wave Quantum Inc. (NYSE:QBTS) is among the 10 Stocks That Could Double Over the Next 2 Years. On June 1, Roth Capital raised its price target on D-Wave ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. D-Wave Quantum shares are up 46% in 2025 with help from a 509% pop ...

D-Wave Quantum receives a Sell rating due to lagging technology, negligible revenues, and an excessive forward P/S multiple. QBTS's pivot to gate-model quantum via the Quantum Circuits acquisition is ...

However, while QBTS shares spiked in mid-March on news of the first of these advances, they have faltered since then. As of April 1, QBTS is actually down nearly 24% year-to-date (YTD). For many ...

Explore how two quantum innovators stack up on customer reach, financial health, and risk as they race for commercial leadership in a fast-evolving sector.